ArticleDiagnostics (Basel, Switzerland)2021

Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up.

Suguru Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.